| Marissa Ann Lehmann, PT, DPT | |
|
14857 Southwest Fwy # 303, Sugar Land, TX 77478-5016 | |
| (281) 242-8900 | |
| Not Available |
| Full Name | Marissa Ann Lehmann |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 14857 Southwest Fwy # 303, Sugar Land, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053074617 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1351330 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marissa Ann Lehmann, PT, DPT 15838 Heritage Falls Dr, Friendswood, TX 77546-2931 Ph: () - | Marissa Ann Lehmann, PT, DPT 14857 Southwest Fwy # 303, Sugar Land, TX 77478-5016 Ph: (281) 242-8900 |
News Archive
Kyto Biopharma Inc., is pleased to announce that it has signed a licensing agreement with the Research Foundation of the State University of New York. The licensing agreement grants Kyto patent rights to the Transcobalamin (Vitamin B12) Receptor and to an additional broad group of other patents which are critical to Kyto's research and development strategy for the treatment of cancer.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
Scientists have discovered how the gene mutation responsible for fragile X syndrome - the most common inherited form of mental retardation - alters the way brain cells communicate.
Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.
› Verified 3 days ago
Rehab Experts Katy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1110 Lakeview Dr, Sugar Land, TX 77478 Phone: 832-348-7298 | |
Sienna Kahlden, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 17520 W Grand Pkwy S Ste 100, Sugar Land, TX 77479 Phone: 281-725-5895 | |
Ms. Soraya C Rodriguez, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15400 Southwest Fwy, Suite 100, Sugar Land, TX 77478 Phone: 281-565-8800 Fax: 281-565-8808 | |
Laura B Thomas-cousar, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13130 Cane Lake Ct, Sugar Land, TX 77498 Phone: 713-334-1818 | |
Robert Horry Center For Sports And Physical Rehabilitation, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15591 Creek Bend Dr, Sugar Land, TX 77478 Phone: 281-277-0751 Fax: 281-277-0761 | |
Ms. Megan Leigh Ellis, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 20403 University Blvd Ste 100, Sugar Land, TX 77478 Phone: 281-325-0188 Fax: 281-325-0189 | |
Erich Hunter Gaulke, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4945 Sweetwater Blvd, Sugar Land, TX 77479 Phone: 281-277-1330 |